Search

A team at UT Southwestern Medical Center is the first in North Texas to offer single-port robotic-assisted thoracoscopic lobectomy, a minimally invasive procedure for select patients with early-stage lung cancer.

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug.

Researchers at UT Southwestern Medical Center have developed a computational method that reveals how immune cells navigate the complex environment inside tumors, offering insights that could inform future cancer therapies.

Past Community Engagement Events

Explore Junior focuses on encouraging curiosity, building confidence, and helping young learners see themselves in science, research, health care, and public health careers. We emphasize fun, interactive STEM activities, exploration, and early identity formation in STEM.

Overview of the Psychiatry Neuroscience Division in the Department of Psychiatry at UT Southwestern

The UT Southwestern Ethics Grand Rounds is a series of scholarly lectures addressing the most pressing bioethics issues of our day.

Patient Outcomes Fully Equipped Rehab Gym at Zale Lipshy Pavilion – William P. Clements Jr. University Hospital UT Southwestern Medical Center's Inpatient Rehabilitation Program helps patients with a variety of diagnoses to return to their everyday lives. Patients receive one-on-one therapies as well…

The annual Daniel W. Foster, M.D., Visiting Lectureship in Medical Ethics brings the most distinguished medical ethics scholars to the UT Southwestern campus.

Siyuan Zhang Awarded NIH R01 Grant to Study Metastatic Ovarian Cancer Published on: August 06, 2026 Siyuan Zhang, M.D., Ph.D. has been awarded an NIH R01 grant to study metastatic ovarian cancer. Dr. Siyuan Zhang Dr. Siyuan Zhang, Associate Professor of Pathology, has received an NIH R01 grant to inv…